{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:40:19Z","timestamp":1792701619572,"version":"4.5.0"},"reference-count":38,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2025,10,1]]},"abstract":"Importance<\/jats:title>The overdiagnosis of melanoma in situ (MIS) is well documented. There is limited evidence on the rate of local recurrence of the non-lentigo maligna (non-LM)\/non-acral lentiginous melanoma (non-ALM) subtypes.<\/jats:p><\/jats:sec>Objective<\/jats:title>To investigate local recurrence and prognosis in non-LM\/non-ALM MIS, the histopathological clearance of the excisional biopsy margins, and the association with the size of wide excision margins.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This retrospective cohort study included patients with non-LM\/non-ALM MIS diagnosed from 1991 to 2023 who were followed up for at least 1 year at the Skin Cancer and Melanoma Unit of Andreas Sygros University Hospital in Athens, Greece. Patients with a history of invasive melanoma or a histopathological diagnosis of LM or ALM in situ were excluded. Median (IQR) follow-up was 5.2 (2.9-7.9) years. Deidentified data on patient demographics and clinical characteristics, including the histopathological clearance of margins of the initial excisional biopsy and the size of margins of the wide excision, were obtained from medical records.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>The primary outcomes were local recurrence, metastasis, and melanoma-specific survival.<\/jats:p><\/jats:sec>Results<\/jats:title>A total of 401 patients (214 [53.4%] women) with 403 non-LM\/non-ALM MIS and a median (IQR) age of 52 (40-62) years were included in the analysis. MIS was frequently located on the trunk (201 lesions [49.9%]), followed by the lower extremity (99 [24.6%]), the upper extremity (71 [17.6%]), and the head and neck (32 [7.9%]). All lesions were initially treated with excisional biopsy, followed by wide excision for 372 (92.3%). There was only 1 local recurrence in a patient with involved margins at the excisional biopsy who did not undergo wide excision and developed an invasive melanoma 14 months later. Thirty lesions in 30 patients had clear excisional biopsy margins with no wide excision and had no recurrence at a median (IQR) follow-up of 8.1 (4.1-12.9) years. In 23 patients with 23 lesions that had wide excision with narrower than the standard 0.5-cm margins (mean [SD] margin size, 0.36 [0.07] cm), no recurrences were found at a median (IQR) follow-up of 4.3 (2.7-6.2) years. During follow-up, 6 patients (1.5%) developed a lesion suspicious for recurrence near the excision scar, which was excised and showed nevus or solar lentigo on histopathology. No patients had metastasis or melanoma-specific death.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>This cohort study found that diagnostic excisional biopsies with clear margins may be sufficient for treating MIS; however, larger studies are necessary.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamadermatol.2025.3078","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T15:00:55Z","timestamp":1756911655000},"page":"1002","source":"Crossref","is-referenced-by-count":7,"title":["Local Recurrence and Survival in Patients With Melanoma In Situ"],"prefix":"10.1001","volume":"161","author":[{"given":"Clio","family":"Dessinioti","sequence":"first","affiliation":[{"name":"First Department of Dermatology-Venereology, National and Kapodistrian University of Athens, Andreas Sygros Hospital, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aggeliki","family":"Befon","sequence":"additional","affiliation":[{"name":"State Department of Dermatology-Venereology, Andreas Sygros Hospital, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihaella","family":"Plaka","sequence":"additional","affiliation":[{"name":"First Department of Dermatology-Venereology, National and Kapodistrian University of Athens, Andreas Sygros Hospital, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikaterini","family":"Niforou","sequence":"additional","affiliation":[{"name":"First Department of Dermatology-Venereology, National and Kapodistrian University of Athens, Andreas Sygros Hospital, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Kypreou","sequence":"additional","affiliation":[{"name":"First Department of Dermatology-Venereology, National and Kapodistrian University of Athens, Andreas Sygros Hospital, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan C.","family":"Geller","sequence":"additional","affiliation":[{"name":"Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J.","family":"Stratigos","sequence":"additional","affiliation":[{"name":"First Department of Dermatology-Venereology, National and Kapodistrian University of Athens, Andreas Sygros Hospital, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"doi250043r1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2024.115153","article-title":"European consensus-based interdisciplinary guideline for melanoma. part 2: treatment: update 2024.","volume":"215","author":"Garbe","year":"2025","journal-title":"Eur J Cancer"},{"issue":"4","key":"doi250043r3","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.jaad.2016.05.011","article-title":"Trends in the diagnosis and clinical features of melanoma in situ (MIS) in US men and women: a prospective, observational study.","volume":"75","author":"Wei","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"doi250043r4","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/bjd\/ljae175","article-title":"Increasing melanoma incidence with unchanged mortality: more sunshine, better treatment, increased diagnostic activity, overdiagnosis or lowered diagnostic threshold?","volume":"191","author":"Nielsen","year":"2024","journal-title":"Br J Dermatol"},{"issue":"7","key":"doi250043r5","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1001\/jamadermatol.2023.1494","article-title":"Risk of mortality after a diagnosis of melanoma in situ.","volume":"159","author":"Patel","year":"2023","journal-title":"JAMA Dermatol"},{"issue":"6","key":"doi250043r6","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/bjd\/ljad033","article-title":"\u2018Get data out\u2019 skin: national cancer registry incidence and survival rates for all registered skin tumour groups for 2013-2019 in England.","volume":"188","author":"van Bodegraven","year":"2023","journal-title":"Br J Dermatol"},{"issue":"1","key":"doi250043r7","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1056\/NEJMsb2019760","article-title":"The rapid rise in cutaneous melanoma diagnoses.","volume":"384","author":"Welch","year":"2021","journal-title":"N Engl J Med"},{"issue":"6","key":"doi250043r8","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1093\/bjd\/ljae296","article-title":"Estimating the magnitude and healthcare costs of melanoma in situ and thin invasive melanoma overdiagnosis in Australia.","volume":"191","author":"Lindsay","year":"2024","journal-title":"Br J Dermatol"},{"issue":"11","key":"doi250043r9","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1002\/pon.4366","article-title":"Fear of new or recurrent melanoma after treatment for localised melanoma.","volume":"26","author":"Bell","year":"2017","journal-title":"Psychooncology"},{"issue":"1","key":"doi250043r10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/CMR.0000000000001007","article-title":"Psychosocial wellbeing in people with melanoma in-situ: a systematic review.","volume":"35","author":"Zheng","year":"2025","journal-title":"Melanoma Res"},{"issue":"7","key":"doi250043r11","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/ddg.15699","article-title":"Local recurrence of non-lentigo maligna melanoma in situ and safety excision margins: A systematic review.","volume":"23","author":"Dessinioti","year":"2025","journal-title":"J Dtsch Dermatol Ges"},{"key":"doi250043r12","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.ejca.2022.04.018","article-title":"European consensus-based interdisciplinary guideline for melanoma. part 2: treatment - update 2022.","volume":"170","author":"Garbe","year":"2022","journal-title":"Eur J Cancer"},{"issue":"8","key":"doi250043r14","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1001\/jamadermatol.2024.1878","article-title":"Recurrence rate of small melanoma in situ on low-risk sites excised with 5-mm excisional margin.","volume":"160","author":"Sun","year":"2024","journal-title":"JAMA Dermatol"},{"issue":"3","key":"doi250043r15","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.jaad.2021.04.090","article-title":"Systematic review and meta-analysis of local recurrence rates of head and neck cutaneous melanomas after wide local excision, Mohs micrographic surgery, or staged excision.","volume":"85","author":"Bittar","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"doi250043r16","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/DSS.0000000000003683","article-title":"Local recurrence rates of malignant melanoma after Mohs micrographic surgery are lowest with 5- to 10-mm initial margins: a systematic review and meta-analysis.","volume":"49","author":"Campbell","year":"2023","journal-title":"Dermatol Surg"},{"key":"doi250043r17","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jdin.2022.06.001","article-title":"Association between excision margins and local recurrence in 1407 patients with primary in situ melanomas.","volume":"8","author":"Gaetano","year":"2022","journal-title":"JAAD Int"},{"issue":"5","key":"doi250043r18","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1093\/bjd\/ljad031","article-title":"Is it time we changed the way we manage melanoma in situ of the trunk and limbs?","volume":"188","author":"Smith","year":"2023","journal-title":"Br J Dermatol"},{"issue":"1","key":"doi250043r19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/DSS.0000000000002417","article-title":"Recurrence and mortality of melanoma in situ of the trunk or extremities: a surveillance, epidemiology, and end results analysis.","volume":"47","author":"Daniel","year":"2021","journal-title":"Dermatol Surg"},{"issue":"5","key":"doi250043r20","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1001\/jamadermatol.2016.6138","article-title":"Outcomes of melanoma in situ treated with Mohs micrographic surgery compared with wide local excision.","volume":"153","author":"Nosrati","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"3","key":"doi250043r21","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.bjps.2013.11.014","article-title":"Surgical excision margins for melanoma in situ.","volume":"67","author":"Akhtar","year":"2014","journal-title":"J Plast Reconstr Aesthet Surg"},{"issue":"7","key":"doi250043r22","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1001\/jamadermatol.2023.1485","article-title":"Melanoma in situ-getting the diagnosis and prognosis right.","volume":"159","author":"Cust","year":"2023","journal-title":"JAMA Dermatol"},{"issue":"4","key":"doi250043r23","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1001\/jamadermatol.2017.6448","article-title":"Dermoscopy and overdiagnosis of melanoma in situ.","volume":"154","author":"Nufer","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"6","key":"doi250043r24","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/S0046-8177(96)90157-4","article-title":"Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists.","volume":"27","author":"Farmer","year":"1996","journal-title":"Hum Pathol"},{"issue":"1","key":"doi250043r25","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.50613","article-title":"Revision of the melanocytic pathology assessment tool and hierarchy for diagnosis classification schema for melanocytic lesions: a consensus statement.","volume":"6","author":"Barnhill","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"10","key":"doi250043r26","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1093\/jnci\/djac138","article-title":"Incidence of in situ vs invasive melanoma: testing the \u201cobligate precursor\u201d hypothesis.","volume":"114","author":"Olsen","year":"2022","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"doi250043r27","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1111\/jdv.18453","article-title":"A review of nevus-associated melanoma: what is the evidence?","volume":"36","author":"Dessinioti","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"doi250043r28","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/bjd.19819","article-title":"A multicentre study of naevus-associated melanoma vs. de novo melanoma, tumour thickness and body site differences.","volume":"185","author":"Dessinioti","year":"2021","journal-title":"Br J Dermatol"},{"issue":"12","key":"doi250043r29","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S0046-8177(84)80310-X","article-title":"A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma.","volume":"15","author":"Clark","year":"1984","journal-title":"Hum Pathol"},{"issue":"20","key":"doi250043r30","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1056\/NEJMoa1502583","article-title":"The genetic evolution of melanoma from precursor lesions.","volume":"373","author":"Shain","year":"2015","journal-title":"N Engl J Med"},{"issue":"1","key":"doi250043r31","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ccell.2018.06.005","article-title":"Genomic and transcriptomic analysis reveals incremental disruption of key signaling pathways during melanoma evolution.","volume":"34","author":"Shain","year":"2018","journal-title":"Cancer Cell"},{"issue":"3","key":"doi250043r32","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1001\/jamadermatol.2015.3775","article-title":"Association of patient risk factors and frequency of nevus-associated cutaneous melanomas.","volume":"152","author":"Haenssle","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"8","key":"doi250043r33","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1016\/j.jid.2017.12.036","article-title":"Factors related to nevus-associated cutaneous melanoma: a case-case study.","volume":"138","author":"Pandeya","year":"2018","journal-title":"J Invest Dermatol"},{"issue":"3","key":"doi250043r34","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1001\/archderm.139.3.282","article-title":"The transformation rate of moles (melanocytic nevi) into cutaneous melanoma: a population-based estimate.","volume":"139","author":"Tsao","year":"2003","journal-title":"Arch Dermatol"},{"issue":"6","key":"doi250043r35","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1111\/bjd.21010","article-title":"Do we need to rethink the diagnoses melanoma in?situ and severely dysplastic naevus?","volume":"186","author":"Semsarian","year":"2022","journal-title":"Br J Dermatol"},{"issue":"12","key":"doi250043r36","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/S0046-8177(06)80029-8","article-title":"Malignant melanoma in situ.","volume":"21","author":"Clark","year":"1990","journal-title":"Hum Pathol"},{"issue":"4","key":"doi250043r37","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1111\/j.1365-2133.2008.08994.x","article-title":"Shrinkage of skin excision specimens: formalin fixation is not the culprit.","volume":"160","author":"Dauendorffer","year":"2009","journal-title":"Br J Dermatol"},{"issue":"1","key":"doi250043r38","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1245\/s10434-018-6858-y","article-title":"Correlation between surgical and histologic margins in melanoma wide excision specimens.","volume":"26","author":"Friedman","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"doi250043r2","unstructured":"Swetter? SM, Johnson? D, Albertini? MR, . National Comprehensive Cancer Network Guidelines. Melanoma: cutaneous. version 2.2025\u2014January 28, 2025. Accessed on February 15, 2025. https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&id=1492"},{"key":"doi250043r13","unstructured":"Strengthening the reporting of observational studies in epidemiology: STROBE checklists. Accessed on November 24, 2023. https:\/\/www.strobe-statement.org\/checklists\/"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2838218\/jamadermatology_dessinioti_2025_oi_250043_1760475168.3899.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:02:23Z","timestamp":1760540543000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2838218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2025.3078","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,1]]}}}